52

Aurobindo Pharma LtdBOM 524804 Stock Report

Last reporting period 31 Mar, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

4.188

Middle

Exchange

XBOM - Bombay Stock Exchange

View Section: Price ratios

Aurobindo Statements

52

Data from Aurobindo`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

INR - Indian rupee

Last reporting period:

31 Mar, 2024

Next reporting period:

27 Sep, 2024

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

07 Nov, 2024

Aurobindo Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

INR (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-03-31
%

149 319.3

6.1 %

100

62 114.5

41.6

87 204.8

13.6 %

58.4

0

20 160

13.5

62 096.8

5.8 %

41.6

25 108

38.7 %

16.8

-1 493.4

-1.0001

2 529.7

1.7

24 923.2

32 %

16.7

6 450

4.3

18 450.4

38.9 %

12.4

31.601

583.86

2023-09-30
%

140 699.4

9.2 %

100

63 914.5

44.8

76 784.9

9 %

55.2

0

19 069.4

13.2

58 679.5

1.3 %

41.5

18 105.4

44.8 %

13.7

-1 187.5

-1.3

2 656.3

2.6

18 876.7

33.9 %

14.9

5 660.2

4.5

13 279.3

33.1 %

10.5

22.57

588.07

2023-03-31
%

128 800.6

7.6 %

100

58 385.7

45.3

70 415.9

8 %

54.7

0

17 736

13.2

57 914.6

9.3 %

45.2

12 500.3

2.1 %

9.5

478.7

0.01

1 122.6

1.7

14 101.6

17.3 %

11.3

4 132.5

3.5

9 975.7

7.3 %

7.8

17.016

586.13

2022-09-30
%

119 753

1.4 %

100

54 547

44.7

65 205

-0.3 %

55.3

0

17 487

15.1

52 966

3.8 %

45.9

12 240

-14.9 %

9.4

-1 195

-1.3

978

1

12 024

-13.3 %

9.1

2 716

2

9 300

-21.3 %

7.1

15.87

586

2022-03-31
%

118 116

1.4 %

100

52 684

43.5

65 432

-3.4 %

56.5

0

17 221

14.7

51 051

3.1 %

44.1

14 381

-21.1 %

12.4

29

0.1

744

0.5

13 874

-30.1 %

10.2

2 070

0.3

11 812

-19.5 %

9.9

20.16

586

2021-09-30
%

116 439

-5.8 %

100

48 718

42.2

67 721

-8.3 %

57.8

0

17 288

14.5

49 499

-6.4 %

42.8

18 222

-13.3 %

15

-129

-0.3

1 760

1.6

19 853

-60.8 %

16.3

5 186

4.6

14 670

-60.9 %

11.7

25.03

586

2021-03-31
%

123 664

-0.3 %

100

49 794

40.1

73 870

-1.3 %

59.9

0

17 351

14.2

52 864

-0.4 %

43.1

21 007

-3.5 %

16.8

142

-0.2

1 367

1.1

50 663

122.5 %

17.7

13 172

4.3

37 497

135.9 %

13.4

63.99

586

2020-09-30
%

124 082

2.9 %

100

49 231

38.8

74 851

7.2 %

61.2

0

17 999

14.1

53 079

7.9 %

43.1

21 773

5.3 %

18.1

-406

-0.5

1 406

0.7

22 774

13 %

18.4

6 885

6

15 893

1.3 %

12.4

27.07

587

2020-03-31
%

120 534

9.1 %

100

50 684

40.7

69 851

9.5 %

59.4

0

16 621

14

49 172

8.1 %

41.3

20 679

13 %

18

-1 061

-1.3

546

0.5

20 157

16.7 %

17.5

4 473

3.5

15 695

23 %

14

26.79

586

2019-09-30
%

110 451

100

46 668

42.3

63 783

57.7

0

15 571

13.9

45 486

41.2

18 297

16.5

-1 085

-1.2

316

0.4

17 273

15.4

4 522

4

12 757

11.4

21.77

586

View Section: Balance Sheet